Alnylam Pharmaceuticals is seeking an imaginative physician drug developer to lead clinical programs across neurology and hematology. The Director will provide clinical leadership in developing RNAi therapeutics and drive progress from Phase 2 to Phase 3, reporting to the program strategy lead and collaborating with regulatory, biostatistics, clinical operations, preclinical, and medical affairs teams.
The role emphasizes serving as a development spokesperson at external meetings and regulatory
Director, Clinical Research — RNAi Therapeutics Lead in Maidenhead employer: Alnylam Pharmaceuticals, Inc.
At Alnylam, we pride ourselves on being an exceptional employer, offering a dynamic work culture that fosters collaboration and innovation in the field of biostatistics. Our Maidenhead office provides a hybrid working model, allowing for flexibility while ensuring strong team engagement. We are committed to employee growth, providing opportunities for professional development and involvement in cutting-edge clinical trials that make a meaningful impact on healthcare.
Contact Details:
Alnylam Pharmaceuticals, Inc. Recruitment Team
